Agosti , V , Nunes , E , Levin , F ( 2002 ). Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence . American Journal of Drug and Alcohol Abuse 28 , 643 – 652 .

Andreasen , NC , Flaum , M , Arndt , S ( 1992 ). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology . Archives of General Psychiatry 49 , 615 – 623 .

APA ( 2000 ). Diagnostic and Statistical Manual of Mental Disorders . American Psychiatric Association : Washington, DC .

Baeza , I , Graell , M , Moreno , D , Castro-Fornieles , J , Parellada , M , Gonzalez-Pinto , A , Paya , B , Soutullo , C , de la Serna , E , Arango , C ( 2009 ). Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study) . Schizophrenia Research 113 , 129 – 137 .

Baker , AL , Hides , L , Lubman , DI ( 2010 ). Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review . Journal of Clinical Psychiatry 71 , 247 – 254 .

Barbeito , S , Vega , P , Ruiz de Azúa , S , Saenz , M , Martinez-Cengotitabengoa , M , González-Ortega , I , Bermudez , C , Hernanz , M , Corres , BF , González-Pinto , A ( 2013 ). Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study . BMC Psychiatry 13 , 326 .

Barrowclough , C , Emsley , R , Eisner , E , Beardmore , R , Wykes , T ( 2013 ). Does change in cannabis use in established psychosis affect clinical outcome? Schizophrenia Bulletin 39 , 339 – 348 .

Brunette , MF , Mueser , KT , Xie , H , Drake , RE ( 1997 ). Relationships between symptoms of schizophrenia and substance abuse . Journal of Nervous and Mental Disease 185 , 13 – 20 .

Burns , JK , Jhazbhay , K , Emsley , R ( 2010 ). Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study . African Journal of Psychiatry 13 , 395 – 399 .

Caseiro , O , Perez-Iglesias , R , Mata , I , Martinez-Garcia , O , Pelayo-Teran , JM , Tabares-Seisdedos , R , Ortiz-Garcia de la Foz , V , Vazquez-Barquero , JL , Crespo-Facorro , B ( 2012 ). Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study . Journal of Psychiatric Research 46 , 1099 – 1105 .

Clausen , L , Hjorthoj , CR , Thorup , A , Jeppesen , P , Petersen , L , Bertelsen , M , Nordentoft , M ( 2014 ). Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial . Psychological Medicine 44 , 117 – 126 .

Degenhardt , L , Tennant , C , Gilmour , S , Schofield , D , Nash , L , Hall , W , McKay , D ( 2007 ). The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study . Psychological Medicine 37 , 927 – 934 .

DeLisi , LE ( 1992 ). The significance of age of onset for schizophrenia . Schizophrenia Bulletin 18 , 209 – 215 .

Dixon , L ( 1999 ). Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes . Schizophrenia Research 35 ( Suppl. ), S93 – S100 .

D'Souza , DC , Perry , E , MacDougall , L , Ammerman , Y , Cooper , T , Wu , YT , Braley , G , Gueorguieva , R , Krystal , JH ( 2004 ). The psychotomimetic effects of intravenous Δ−9-tetrahydrocannabinol in healthy individuals: implications for psychosis . Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 29 , 1558 – 1572 .

Faber , G , Smid , HG , Van Gool , AR , Wunderink , L , van den Bosch , RJ , Wiersma , D ( 2012 ). Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial . Journal of Clinical Psychiatry 73 , 632 – 638 .

Fergusson , DM , Horwood , LJ , Swain-Campbell , N ( 2002 ). Cannabis use and psychosocial adjustment in adolescence and young adulthood . Addiction (Abingdon, England) 97 , 1123 – 1135 .

Foti , DJ , Kotov , R , Guey , LT , Bromet , EJ ( 2010 ). Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization . American Journal of Psychiatry 167 , 987 – 993 .

Gonzalez-Pinto , A , Alberich , S , Barbeito , S , Gutierrez , M , Vega , P , Ibanez , B , Haidar , MK , Vieta , E , Arango , C ( 2011 ). Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use . Schizophrenia Bulletin 37 , 631 – 639 .

Grech , A , Van Os , J , Jones , PB , Lewis , SW , Murray , RM ( 2005 ). Cannabis use and outcome of recent onset psychosis . European Psychiatry: The Journal of the Association of European Psychiatrists 20 , 349 – 353 .

Hettema , J , Steele , J , Miller , WR ( 2005 ). Motivational interviewing . Annual Review of Clinical Psychology 1 , 91 – 111 .

Hides , L , Dawe , S , Kavanagh , DJ , Young , RM ( 2006 ). Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study . British Journal of Psychiatry: The Journal of Mental Science 189 , 137 – 143 .

Hinton , M , Edwards , J , Elkins , K , Harrigan , SM , Donovan , K , Purcell , R , McGorry , PD ( 2007 ). Reductions in cannabis and other illicit substance use between treatment entry and early recovery in patients with first-episode psychosis . Early Intervention in Psychiatry 1 , 259 – 266 .

Howes , OD , Montgomery , AJ , Asselin , MC , Murray , RM , Valli , I , Tabraham , P , Bramon-Bosch , E , Valmaggia , L , Johns , L , Broome , M , McGuire , PK , Grasby , PM ( 2009 ). Elevated striatal dopamine function linked to prodromal signs of schizophrenia . Archives of General Psychiatry 66 , 13 – 20 .

Jones , SH , Thornicroft , G , Coffey , M , Dunn , G ( 1995 ). A brief mental health outcome scale – reliability and validity of the Global Assessment of Functioning (GAF) . British Journal of Psychiatry: The Journal of Mental Science 166 , 654 – 659 .

Kay , SR , Fiszbein , A , Opler , LA ( 1987 ). The positive and negative syndrome scale (PANSS) for schizophrenia . Schizophrenia Bulletin 13 , 261 – 276 .

Knudsen , P , Vilmar , T ( 1984 ). Cannabis and neuroleptic agents in schizophrenia . Acta Psychiatrica Scandinavica 69 , 162 – 174 .

Korver , N , Quee , PJ , Boos , HB , Simons , CJ , de Haan , L , GROUP Investigators ( 2012 ). Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment and assessment methods . International Journal of Methods in Psychiatric Research 21 , 205 – 221 .

Koskinen , J , Lohonen , J , Koponen , H , Isohanni , M , Miettunen , J ( 2010 ). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis . Schizophrenia Bulletin 36 , 1115 – 1130 .

Kuepper , R , van Os , J , Lieb , R , Wittchen , HU , Hofler , M , Henquet , C ( 2011 ). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study . BMJ (Clinical Research ed.) 342 , d738 .

Kuepper , R , van Winkel , R , Henquet , C ( 2013 ). Cannabis use and the risk of psychotic disorders. An update . Tijdschrift voor Psychiatrie 55 , 867 – 872 .

Lincoln , TM , Lullmann , E , Rief , W ( 2007 ). Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review . Schizophrenia Bulletin 33 , 1324 – 1342 .

Linszen , DH , Dingemans , PM , Lenior , ME ( 1994 ). Cannabis abuse and the course of recent-onset schizophrenic disorders . Archives of General Psychiatry 51 , 273 – 279 .

Maremmani , I , Lazzeri , A , Pacini , M , Lovrecic , M , Placidi , GF , Perugi , G ( 2004 ). Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status . Journal of Psychoactive Drugs 36 , 235 – 241 .

Martinez-Arevalo , MJ , Calcedo-Ordonez , A , Varo-Prieto , JR ( 1994 ). Cannabis consumption as a prognostic factor in schizophrenia . British Journal of Psychiatry: The Journal of Mental Science 164 , 679 – 681 .

Mullin , K , Gupta , P , Compton , MT , Nielssen , O , Harris , A , Large , M ( 2012 ). Does giving up substance use work for patients with psychosis? A systematic meta-analysis . Australian and New Zealand Journal of Psychiatry 46 , 826 – 839 .

Negrete , JC , Knapp , WP ( 1986 ). The effects of cannabis use on the clinical condition of schizophrenics . NIDA Research Monograph 67 , 321 – 327 .

Peralta , V , Cuesta , MJ ( 1992 ). Influence of cannabis abuse on schizophrenic psychopathology . Acta Psychiatrica Scandinavica 85 , 127 – 130 .

Pijlman , F , Rigter , S , Hoek , J , Goldschmidt , H , Niesink , R ( 2005 ). Strong increase in total Δ-THC in cannabis preparations sold in Dutch coffee shops . Addiction Biology 10 , 171 – 180 .

Poulin , C , Hand , D , Boudreau , B , Santor , D ( 2005 ). Gender differences in the association between substance use and elevated depressive symptoms in a general adolescent population . Addiction (Abingdon, England) 100 , 525 – 535 .

Regier , DA , Farmer , ME , Rae , DS , Locke , BZ , Keith , SJ , Judd , LL , Goodwin , FK ( 1990 ). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study . JAMA: The Journal of the American Medical Association 264 , 2511 – 2518 .

Rey , JM , Tennant , CC ( 2002 ). Cannabis and mental health . BMJ (Clinical Research ed.) 325 , 1183 – 1184 .

Smeerdijk , M , Keet , R , de Haan , L , Barrowclough , C , Linszen , D , Schippers , G ( 2014 ). Feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use . Journal of Substance Abuse Treatment 46 , 340 – 345 .

Smeerdijk , M , Keet , R , Dekker , N , van Raaij , B , Krikke , M , Koeter , M , de Haan , L , Barrowclough , C , Schippers , G , Linszen , D ( 2012 ). Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial . Psychological Medicine 42 , 1627 – 1636 .

Stirling , J , Lewis , S , Hopkins , R , White , C ( 2005 ). Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up . Schizophrenia Research 75 , 135 – 137 .

Swartz , MS , Wagner , HR , Swanson , JW , Stroup , TS , McEvoy , JP , Reimherr , F , Miller , DD , McGee , M , Khan , A , Canive , JM , Davis , SM , Hsiao , JK , Lieberman , JA , CATIE Investigators ( 2008 ). The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study . Schizophrenia Research 100 , 39 – 52 .

van Os , J , Kenis , G , Rutten , BP ( 2010 ). The environment and schizophrenia . Nature 468 , 203 – 212 .

Wade , D , Harrigan , S , McGorry , PD , Burgess , PM , Whelan , G ( 2007 ). Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis . Journal of Clinical Psychiatry 68 , 767 – 774 .

Wilk , J , Marcus , SC , West , J , Countis , L , Hall , R , Regier , DA , Olfson , M ( 2006 ). Substance abuse and the management of medication nonadherence in schizophrenia . Journal of Nervous and Mental Disease 194 , 454 – 457 .

Wing , JK , Babor , T , Brugha , T , Burke , J , Cooper , JE , Giel , R , Jablenski , A , Regier , D , Sartorius , N ( 1990 ). SCAN. Schedules for Clinical Assessment in Neuropsychiatry . Archives of General Psychiatry 47 , 589 – 593 .

World Health Organization ( 1990 ). Composite International Diagnostic Interview (CIDI): (a) CIDI-interview (version 1.0), (b) CIDI-user manual, (c) CIDI-training manual, (d) CIDI-computer programs . World Health Organization : Geneva .